Of the identified TFs, FOXC1 is known to inhibit the migration and invasion of pituitary tumor cells under the regulation of has-mir-133; furthermore, members of the FOXC1 family are already known as drug targets for cancer (41, 42). This evidence concerns the gene FOXC1 and cancer.